News Announcement

Suraksha Diagnostic: Board Meeting Intimation for Inter-Alia Considering And Approving Audited (Standalone And Consolidated) Financial Results Of The Company For Quarter And FY 2025-26 And To Consider Recommendation Of Dividend If Any On Equity Shares Of Company For FY 2025-26.

Suraksha Diagnostic Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/05/2026 inter alia to consider and approve 1. Considering and approving the audited (standalone and consolidated) financial results of the Company for the quarter and financial year ended 31 March 20262. To consider recommendation of dividend if any on equity shares of the Company for the financial year ended 31 March 20263. Any other business/ general

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.